R-maxi-CHOP Regimen

Preferred Label : R-maxi-CHOP Regimen;

NCIt synonyms : Rituximab Plus Maximum-strength CHOP Regimen; Rituximab/Maximum-strength CHOP Regimen; Rituximab Plus Maximum-strength Cyclophosphamide/Hydroxydaunorubicin/Oncovin/Prednisone Regimen; Rituximab/Maximum-strength Cyclophosphamide-Doxorubicin-Vincristine-Prednisone Regimen; Rituximab Plus Maximum-strength Cyclophosphamide/Doxorubicin/Vincristine/Prednisone Regimen; Rituximab Plus Maximum-strength Cyclophosphamide/Doxorubicin/Prednisone/Vincristine Regimen;

NCIt definition : A regimen consisting of rituximab and maximum-strength cyclophosphamide, doxorubicin, prednisone and vincristine that may be used for the treatment of mantle cell lymphoma (MCL).;

NCI Metathesaurus CUI : CL1920489;

Détails

Origin ID

C201147;

UMLS CUI

C5856634;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Doxorubicin Hydrochloride [NCIt concept]
- Prednisone [NCIt concept]
- Rituximab [NCIt concept]
- Vincristine Sulfate [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Mantle Cell Lymphoma [NCIt concept]
- Non-Hodgkin Lymphoma [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients